Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro (vol 9, 6078, 2019)

被引：0
|
作者：
Chen, Suxiang [1 ,2 ]
Le, Bao T. [1 ,2 ]
Chakravarthy, Madhuri [1 ,2 ]
Kosbar, Tamer R. [1 ]
Veedu, Rakesh N. [1 ,2 ]
机构：
[1] Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Murdoch, WA 6150, Australia
[2] Perron Inst Neurol & Translat Sci, Perth, WA 6150, Australia
来源：
SCIENTIFIC REPORTS | 2020年 / 10卷 / 01期
关键词：
D O I：
10.1038/s41598-020-63706-0
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
引用
收藏
页数：1
相关论文
共 33 条
  • [1] Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
    Suxiang Chen
    Bao T. Le
    Madhuri Chakravarthy
    Tamer R. Kosbar
    Rakesh N. Veedu
    Scientific Reports, 9
  • [2] Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
    Chen, Suxiang
    Le, Bao T.
    Chakravarthy, Madhuri
    Kosbar, Tamer R.
    Veedu, Rakesh N.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [3] Author Correction: Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
    Suxiang Chen
    Bao T. Le
    Madhuri Chakravarthy
    Tamer R. Kosbar
    Rakesh N. Veedu
    Scientific Reports, 10
  • [4] Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping
    Li, Dunhui
    Mastaglia, Frank L.
    Fletcher, Sue
    Wilton, Steve D.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2018, 39 (11) : 982 - 994
  • [5] Antisense Oligonucleotide-Mediated Exon 27 Skipping of Dysferlin for the Treatment of Dysferlinopathy
    Anwar, Saeed
    Maruyama, Rika
    Yokota, Toshifumi
    MOLECULAR THERAPY, 2022, 30 (04) : 277 - 278
  • [6] New Approach for Antisense Oligonucleotide-Mediated Exon Skipping in Duchenne Muscular Dystrophy
    Aoki, Yoshitsugu
    Nagata, Tetsuya
    Takeda, Shin'ichi
    JOURNAL OF ADVANCED COMPUTATIONAL INTELLIGENCE AND INTELLIGENT INFORMATICS, 2012, 16 (04) : 521 - 526
  • [7] Antisense Oligonucleotide-Mediated Exon Skipping for Duchenne Muscular Dystrophy: Progress and Challenges
    Arechavala-Gomeza, Virginia
    Anthony, Karen
    Morgan, Jennifer
    Muntoni, Francesco
    CURRENT GENE THERAPY, 2012, 12 (03) : 152 - 160
  • [8] THE USE OF ANTISENSE OLIGONUCLEOTIDE-MEDIATED EXON SKIPPING TO TREAT SPINOCEREBELLAR ATAXIA TYPE 3
    McIntosh, Craig S.
    Aung-Htut, May Thander
    Fletcher, Sue
    Wilton, Steve D.
    JOURNAL OF GENE MEDICINE, 2018, 20 (01):
  • [9] Welcome to the splice age: antisense oligonucleotide-mediated exon skipping gains wider applicability
    McNally, Elizabeth M.
    Wyatt, Eugene J.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (04): : 1236 - 1238
  • [10] Progress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy
    Chwalenia, Katarzyna
    Wood, Matthew J. A.
    Roberts, Thomas C.
    JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2025,
1234